From Europe. For the global patent community.
  • JUVE Patent PaceMaker
  • Advertiser Login
  • Firm Rankings
  • Cases
  • Legal Commentary
  • People & Business
  • Sponsored: Firm Profiles
    • Maikowski & Ninnemann
    • BDPE Patent- und Rechtsanwälte
    • BARDEHLE PAGENBERG
    View all Firm Profiles
    Sponsored: Expert Profiles
    • Dr. rer. nat., Dipl.-Phys., Dipl.-Kfm. Georg Anetsberger BARDEHLE PAGENBERG
    • Dr. Marcus Matuschek Finnegan, Henderson, Fara…
    • Benoît Strowel HOYNG ROKH MONEGIER
    View all Expert Profiles
    Sponsored Content
    • 110+ attorneys later: what AI taught … by DeepIP
    • IP Monetization Outlook: Key Insights… by Burford Capital
    • A whole-of-market-evidence approach t… by BRELA / FRANDLY
    View all Sponsored Content
Trending Topics:
  • German patent market
  • Patent rankings Europe
  • Settlements
  • Unified Patent Court
JUVE Patent Biosimilars

Biosimilars

Sponsored Content SPCs

The SPC Manufacturing Waiver: competition through certainty?

The SPC Manufacturing Waiver was introduced just over six years ago, aiming to create a level playing field between EU and non-EU generics and biosimi ...

17 December 2025 by Pinsent Masons LLP
Cases
trastuzumab, Hoffman-La Roche, Mundipharma
Biosimilars

Cancer drug Herceptin: setbacks for Hoffmann-La Roche

Global pharmaceutical company Mundipharma can sell its anti-cancer drug Herzuma in the Netherlands until further notice, as decided by the Rechtbank i ...

1 March 2019 by Mathieu Klos
Popular
  • Cases at Paris patent chamber decline for first time in years
  • Partial victory for GSK against BioNTech and Pfizer in UPC dispute
  • ZTE and Samsung withdraw UPC infringement actions in apparent settlement
© 2026 Juve Patent
 Created with Sketch. LinkedIn
  • Team
  • About us
  • Media Information
  • General Terms and Conditions
  • PaceMaker General Terms & Conditions
  • Privacy Policy
  • Legal Notice
  • Whistleblowing policy
  • Dealing with Artificial Intelligence (AI)
Back to top